Skip to content
PubMed This is a summary of 46 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 46 referenced papers

Top Authors

M. Estela Rubio‐Gozalbo
Maastricht University Medical Centre
Gerard T. Berry
Children's Hospital of Philadelphia
Beate Peter
Arizona State University
Ana I. Coelho
Maastricht University Medical Centre
Didem Demirbas
Boston Children's Hospital
David J. Timson
University of Brighton
Annet M. Bosch
Emma Kinderziekenhuis
Eileen P. Treacy
University College Dublin
Isabel Rivera
University of Lisbon

Top Institutions

Ranked by publications Top 10 institutions

References

References (46)
  1. 1

    Differential Proteomics of Urinary Exovesicles from Classical Galactosemic Patients Reveals Subclinical Kidney Insufficiency.

    Staubach S, Pekmez M, Hanisch FG

    Journal of proteome research 2016; (15(6)):1754-61 doi:10.1021/acs.jproteome.5b00902.

    PMID: 27103203
  2. 2

    Acute and long-term outcomes in a Drosophila melanogaster model of classic galactosemia occur independently of galactose-1-phosphate accumulation.

    Daenzer JM, Jumbo-Lucioni PP, Hopson ML, et al.

    Disease models & mechanisms 2016; (9(11)):1375-1382 doi:10.1242/dmm.022988.

    PMID: 27562100
  3. 3

    The galactose-induced decrease in phosphate levels leads to toxicity in yeast models of galactosemia.

    Machado CM, De-Souza EA, De-Queiroz ALFV, et al.

    Biochimica et biophysica acta. Molecular basis of disease 2017; (1863(6)):1403-1409 doi:10.1016/j.bbadis.2017.02.014.

    PMID: 28213126
  4. 4

    Sweet and sour: an update on classic galactosemia.

    Coelho AI, Rubio-Gozalbo ME, Vicente JB, Rivera I

    Journal of inherited metabolic disease 2017; (40(3)):325-342 doi:10.1007/s10545-017-0029-3.

    PMID: 28281081
  5. 5

    Galactose-1-phosphate uridyltransferase deficiency: A literature review of the putative mechanisms of short and long-term complications and allelic variants.

    Viggiano E, Marabotti A, Politano L, Burlina A

    Clinical genetics 2018; (93(2)):206-215 doi:10.1111/cge.13030.

    PMID: 28374897
  6. 6

    Classic Galactosemia: Study on the Late Prenatal Development of GALT Specific Activity in a Sheep Model.

    Coelho AI, Bierau J, Lindhout M, et al.

    Anatomical record (Hoboken, N.J. : 2007) 2017; (300(9)):1570-1575 doi:10.1002/ar.23616.

    PMID: 28545161
  7. 7

    Fertility in adult women with classic galactosemia and primary ovarian insufficiency.

    van Erven B, Berry GT, Cassiman D, et al.

    Fertility and sterility 2017; (108(1)):168-174 doi:10.1016/j.fertnstert.2017.05.013.

    PMID: 28579413
  8. 8

    Rigor of non-dairy galactose restriction in early childhood, measured by retrospective survey, does not associate with severity of five long-term outcomes quantified in 231 children and adults with classic galactosemia.

    Frederick AB, Cutler DJ, Fridovich-Keil JL

    Journal of inherited metabolic disease 2017; (40(6)):813-821 doi:10.1007/s10545-017-0067-x.

    PMID: 28695375
  9. 9

    Primary ovarian insufficiency in classic galactosemia: current understanding and future research opportunities.

    Thakur M, Feldman G, Puscheck EE

    Journal of assisted reproduction and genetics 2018; (35(1)):3-16 doi:10.1007/s10815-017-1039-7.

    PMID: 28932969
  10. 10

    Inborn Errors of Metabolism with Hepatopathy: Metabolism Defects of Galactose, Fructose, and Tyrosine.

    Demirbas D, Brucker WJ, Berry GT

    Pediatric clinics of North America 2018; (65(2)):337-352 doi:10.1016/j.pcl.2017.11.008.

    PMID: 29502917
  11. 11

    Effect of genotype on galactose-1-phosphate in classic galactosemia patients.

    Yuzyuk T, Balakrishnan B, Schwarz EL, et al.

    Molecular genetics and metabolism 2018; (125(3)):258-265 doi:10.1016/j.ymgme.2018.08.012.

    PMID: 30172461
  12. 12

    Answering a Question Older Than Most Pediatricians: What to Do About Duarte Variant Galactosemia.

    McCandless SE

    Pediatrics 2019; (143(1)) doi:10.1542/peds.2018-3292.

    PMID: 30593448
  13. 13

    Developmental Outcomes in Duarte Galactosemia.

    Carlock G, Fischer ST, Lynch ME, et al.

    Pediatrics 2019; (143(1)) doi:10.1542/peds.2018-2516.

    PMID: 30593450
  14. 14

    Novel Mutation in GALT Gene in Galactosemia Patient with Group B Streptococcus Meningitis and Acute Liver Failure.

    Grama A, Blaga L, Nicolescu A, et al.

    Medicina (Kaunas, Lithuania) 2019; (55(4)) doi:10.3390/medicina55040091.

    PMID: 30987402
  15. 15

    The natural history of classic galactosemia: lessons from the GalNet registry.

    Rubio-Gozalbo ME, Haskovic M, Bosch AM, et al.

    Orphanet journal of rare diseases 2019; (14(1)):86 doi:10.1186/s13023-019-1047-z.

    PMID: 31029175
  16. 16

    RE: Commentary on Developmental Outcomes in Duarte Galactosemia.

    Feder SL

    Pediatrics 2019; (143(5)) doi:10.1542/peds.2019-0477.

    PMID: 31040192
  17. 17

    Screening for galactosemia: is there a place for it?

    Kotb MA, Mansour L, Shamma RA

    International journal of general medicine 2019; (12()):193-205 doi:10.2147/IJGM.S180706.

    PMID: 31213878
  18. 18

    Elevated urine oxalate and renal calculi in a classic galactosemia patient on soy-based formula.

    Sabatino JA, Starin D, Tuchman S, et al.

    JIMD reports 2019; (49(1)):7-10 doi:10.1002/jmd2.12056.

    PMID: 31497475
  19. 19

    Galactosemia.

    Cerone J, Rios A

    Pediatrics in review 2019; (40(Suppl 1)):24-27 doi:10.1542/pir.2018-0150.

    PMID: 31575690
  20. 20

    Therapies for galactosemia: a patent landscape.

    Timson DJ

    Pharmaceutical patent analyst 2020; (9(2)):45-51 doi:10.4155/ppa-2020-0004.

    PMID: 32314655
  21. 21

    Identification of neuronal structures and pathways corresponding to clinical functioning in galactosemia.

    Ahtam B, Waisbren SE, Anastasoaie V, et al.

    Journal of inherited metabolic disease 2020; (43(6)):1205-1218 doi:10.1002/jimd.12279.

    PMID: 32592186
  22. 22

    Hypothalamic-Pituitary Axis Dysfunction after Whole Brain Radiotherapy - A Cohort Study.

    Gebauer J, Mehta P, Fahlbusch FB, et al.

    Anticancer research 2020; (40(10)):5787-5792 doi:10.21873/anticanres.14595.

    PMID: 32988906
  23. 23

    A case of classic galactosemia manifesting as neonatal early and profound indirect hyperbilirubinemia.

    Kavehmanesh Z, Torkaman M, Beiraghdar F

    Turk pediatri arsivi 2020; (55(3)):316-319 doi:10.14744/TurkPediatriArs.2019.21298.

    PMID: 33061763
  24. 24

    Including Classical Galactosaemia in the Expanded Newborn Screening Panel Using Tandem Mass Spectrometry for Galactose-1-Phosphate.

    Cohen AS, Baurek M, Lund AM, et al.

    International journal of neonatal screening 2019; (5(2)):19 doi:10.3390/ijns5020019.

    PMID: 33072978
  25. 25

    Galactose-1-Phosphate Uridyltransferase Activities in Different Genotypes: A Retrospective Analysis of 927 Samples.

    Yuzyuk T, Wilson AR, Mao R, Pasquali M

    The journal of applied laboratory medicine 2018; (3(2)):222-230 doi:10.1373/jalm.2017.025536.

    PMID: 33636947
  26. 26

    Hand fine motor control in classic galactosemia.

    MacWilliams J, Patel S, Carlock G, et al.

    Journal of inherited metabolic disease 2021; (44(4)):871-878 doi:10.1002/jimd.12376.

    PMID: 33720431
  27. 27

    Transient developmental delays in infants with Duarte-2 variant galactosemia.

    Waisbren SE, Tran C, Demirbas D, et al.

    Molecular genetics and metabolism 2021; (134(1-2)):132-138 doi:10.1016/j.ymgme.2021.07.009.

    PMID: 34391645
  28. 28

    Galactosaemia occurring in association with primary ovarian insufficiency, Addison's disease and chronic myeloid leukaemia.

    Khoury B, Shakir MK, Hoang TD

    BMJ case reports 2021; (14(8)) doi:10.1136/bcr-2021-244788.

    PMID: 34433538
  29. 29

    Abnormal N-glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake.

    Treacy EP, Vencken S, Bosch AM, et al.

    JIMD reports 2021; (61(1)):76-88 doi:10.1002/jmd2.12237.

    PMID: 34485021
  30. 30

    Acute and early developmental outcomes of children with Duarte galactosemia.

    Fridovich-Keil JL, Carlock G, Patel S, et al.

    JIMD reports 2022; (63(1)):101-106 doi:10.1002/jmd2.12267.

    PMID: 35028275
  31. 31

    Qualitative interviews with adults with Classic Galactosemia and their caregivers: disease burden and challenges with daily living.

    Randall JA, Sutter C, Wang S, et al.

    Orphanet journal of rare diseases 2022; (17(1)):138 doi:10.1186/s13023-022-02287-9.

    PMID: 35346295
  32. 32

    Transient Cytopenias as a Rare Presentation of Classic Galactosemia.

    Gianniki M, Nikaina I, Avgerinou G, et al.

    Cureus 2022; (14(3)):e23101 doi:10.7759/cureus.23101.

    PMID: 35464534
  33. 33

    Translating principles of precision medicine into speech-language pathology: Clinical trial of a proactive speech and language intervention for infants with classic galactosemia.

    Peter B, Davis J, Finestack L, et al.

    HGG advances 2022; (3(3)):100119 doi:10.1016/j.xhgg.2022.100119.

    PMID: 35677809
  34. 34

    Determination of the lactose and galactose content of common foods: Relevance to galactosemia.

    Shakerdi LA, Wallace L, Smyth G, et al.

    Food science & nutrition 2022; (10(11)):3789-3800 doi:10.1002/fsn3.2976.

    PMID: 36348783
  35. 35

    All aspects of galactosemia: a single center experience.

    Akgun A, Dogan Y

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(1)):29-35 doi:10.1515/jpem-2022-0308.

    PMID: 36399011
  36. 36

    Early postnatal alterations in follicular stress response and survival in a mouse model of Classic Galactosemia.

    Hagen-Lillevik S, Johnson J, Lai K

    Journal of ovarian research 2022; (15(1)):122 doi:10.1186/s13048-022-01049-2.

    PMID: 36414970
  37. 37

    Addition of galactose-1-phosphate measurement enhances newborn screening for classical galactosemia.

    Daas S, Abu Salah N, Anikster Y, et al.

    Journal of inherited metabolic disease 2023; (46(2)):232-242 doi:10.1002/jimd.12580.

    PMID: 36515074
  38. 38

    Virtual Post-Intervention Speech and Language Assessment of Toddler and Preschool Participants in Babble Boot Camp.

    Potter NL, VanDam M, Bruce L, et al.

    Journal of speech, language, and hearing research : JSLHR 2024; (67(9S)):3327-3339 doi:10.1044/2023_JSLHR-22-00687.

    PMID: 37235746
  39. 39

    Twelve-year review of galactosemia newborn screening in Taiwan: Evolving methods and insights.

    Chen HA, Hsu RH, Chen LC, et al.

    Molecular genetics and metabolism reports 2024; (38()):101048 doi:10.1016/j.ymgmr.2024.101048.

    PMID: 38469088
  40. 40

    Clinical and biochemical phenotypes, genotypes, and long-term outcomes of individuals with galactosemia type I from a single metabolic genetics center in Alberta.

    Almenabawy N, Bahl S, Ostlund AL, et al.

    Molecular genetics and metabolism reports 2024; (38()):101055 doi:10.1016/j.ymgmr.2024.101055.

    PMID: 38469090
  41. 41

    Galactose-1-phosphate inhibits cytochrome c oxidase and causes mitochondrial dysfunction in classic galactosemia.

    Machado CM, de-Souza-Ferreira E, Silva GFS, et al.

    Biochimica et biophysica acta. Molecular basis of disease 2024; (1870(7)):167340 doi:10.1016/j.bbadis.2024.167340.

    PMID: 38986816
  42. 42

    Motor Milestones: Sensory Motor Trends of Young Children with Classic Galactosemia.

    Armstrong-Heimsoth A, Monroe A, Cupp C, et al.

    Journal of occupational therapy, schools & early intervention 2024; (17(2)):216-227 doi:10.1080/19411243.2023.2192206.

    PMID: 39185447
  43. 43

    Results of the ACTION-Galactosemia Kids Study to Evaluate the Effects of Govorestat in Pediatric Patients with Classic Galactosemia.

    Bailey E, Phan H, Ahmad A, et al.

    Journal of clinical pharmacology 2025; (65(5)):575-587 doi:10.1002/jcph.6170.

    PMID: 39569553
  44. 44

    Myo-Inositol Deficiency, Structural Brain Changes, and Cerebral Perfusion Alterations in Classic Galactosemia: Preliminary Insights From a Multiparametric MRI Study.

    Niess E, Niess F, Bogner W, et al.

    Journal of inherited metabolic disease 2025; (48(6)):e70097 doi:10.1002/jimd.70097.

    PMID: 41083920
  45. 45

    Coagulopathy in Neonates With Classic Galactosemia: A Life-Threatening Yet Underrecognized Complication.

    Gagen JK, Tinker RJ, Phillips JA, Furuta Y

    Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners 2026; doi:10.1016/j.pedhc.2026.02.001.

    PMID: 41746225
  46. 46

    Galactose tolerance in adults with classical galactosaemia. Considering the gaps.

    Shakerdi LA, Thacker CN, Moore K, et al.

    Molecular genetics and metabolism reports 2026; (46()):101298 doi:10.1016/j.ymgmr.2026.101298.

    PMID: 41798075